This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nseir, G. Articles by Nseir, G. Search for Related Content PubMed PubMed Citation Articles by Nseir, G. Articles by Nseir, G. Social Bookmarking                         What's this?

Successful Percutaneous Balloon Mitral Valvuloplasty in a Patient with Left Atrial Thrombus

A Case Report

Tak Kwan, MD, FACA

Mahandra Mandawat, MD

Alan Feit, MD

Luther T. Clark, MD

Georges Nseir, MD

Interventional Cardiovascular Fellow Arizona Heart Institute Foundation 2632 North 20th Street Phoenix, AZ 85006

Percutaneous balloon mitral valvuloplasty (PBMV) described by Inoue et al, is a safe FDA (Food and Drug Administration) approved procedure in patients with severe mitral stenosis. One of the contraindications of the procedure is presence of a left atrial thrombus; however, it has been reported that intense warfarin therapy may led to disso lution of the thrombus. The authors report a patient who was referred for PBMV and was found to have a left atrial thrombus. After intense warfarin therapy, successful PBMV was undertaken without complications.

Angiology, Vol. 50, No. 3, 255-259 (1999)
DOI: 10.1177/000331979905000311


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?